Just a moment...
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 51.77 |
| 2025-03 | 46.251 |
| 2025-04 | 38.779 |
| 2025-05 | 35.208 |
| Source | Traffic Share |
|---|---|
| search | 55.73% |
| direct | 35.21% |
| referrals | 8.03% |
| social | 0.59% |
| paid referrals | 0.39% |
| 0.04% |
| Region | Percentage |
|---|---|
| United States | 90.51% |
| India | 6.78% |
| Germany | 1.15% |
| United Kingdom | 0.74% |
| Hong Kong | 0.38% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| exelixis | 1,119 | 11,190 | $1.77 |
| exelixis careers | 66 | 660 | $1.72 |
| exel investor relations | 25 | 250 | $0.00 |
| cabozantinib generic | 9 | 90 | $0.00 |
| exelisis | 31 | 310 | $0.00 |